A systematic review and meta-analysis of the association between the neutrophil, lymphocyte, and platelet count, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and COVID-19 progression and mortality

References

• Merad M, Blish CA, Sallusto F, et al., The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122–1127.
   PubMed Web of Science ®Google Scholar
• Garg SS, Sharma A, Gupta J. Immunomodulation and immunotherapeutics of COVID-19. Clin Immunol. 2021;231:108842. DOI:10.1016/j.clim.2021.108842.
   PubMed Web of Science ®Google Scholar
• Garcia LF. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020;11:1441.
   PubMed Web of Science ®Google Scholar
• Tay MZ, Poh CM, Renia L, et al. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363–374.
   PubMed Web of Science ®Google Scholar
• Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021;88(1):15–27.
   PubMed Web of Science ®Google Scholar
• Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1–13.
   PubMed Web of Science ®Google Scholar
• Buja LM, Wolf DA, Zhao B, et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol. 2020;48:107233.
   PubMed Web of Science ®Google Scholar
• Grosse C, Grosse A, Salzer HJF, et al. Analysis of cardiopulmonary findings in COVID-19 fatalities: high incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc Pathol. 2020;49:107263.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Ren L, Zhang L, et al. Heightened innate immune responses in the respiratory tract of COVID-19 patients. Cell Host Microbe. 2020;27(6):883–90 e2.
   PubMed Web of Science ®Google Scholar
• Wilk AJ, Rustagi A, Zhao NQ, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med. 2020;26(7):1070–1076.
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B, Peerschke EI. Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology. J Clin Invest. 2020;130(11):5674–5676.
   PubMed Web of Science ®Google Scholar
• Choudhary S, Sharma K, Silakari O. The interplay between inflammatory pathways and COVID-19: a critical review on pathogenesis and therapeutic options. Microb Pathog. 2021;150:104673.
   PubMed Web of Science ®Google Scholar
• Hariyanto TI, Japar KV, Kwenandar F, et al. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: a systematic review and meta-analysis. Am J Emerg Med. 2021;41:110–119.
   PubMed Web of Science ®Google Scholar
• Ivan Hariyanto T, Kurniawan A. Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection. J Med Virol. 2021;93(3):1832–1836.
   PubMed Web of Science ®Google Scholar
• Paliogiannis P, Mangoni AA, Dettori P, et al. D-dimer concentrations and COVID-19 severity: a systematic review and meta-analysis. Front Public Health. 2020;8:432.
   PubMed Web of Science ®Google Scholar
• Zinellu A, Mangoni AA. Serum complement C3 and C4 and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression. Front Immunol. 2021;12:696085.
   PubMed Web of Science ®Google Scholar
• Zinellu A, Paliogiannis P, Carru C, et al. INR and COVID-19 severity and mortality: a systematic review with meta-analysis and meta-regression. Adv Med Sci. 2021;66(2):372–380.
   PubMed Web of Science ®Google Scholar
• Agbuduwe C, Basu S. Haematological manifestations of COVID-19: from cytopenia to coagulopathy. Eur J Haematol. 2020;105(5):540–546.
   PubMed Web of Science ®Google Scholar
• Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al., Hematological findings and complications of COVID −19. Am J Hematol. 2020;95(7):834–847.
   PubMed Web of Science ®Google Scholar
• Karimi Shahri M, Niazkar HR, Rad F. COVID-19 and hematology findings based on the current evidences: a puzzle with many missing pieces. Int J Lab Hematol. 2021;43(2):160–168.
   PubMed Web of Science ®Google Scholar
• Simadibrata DM, Calvin J, Wijaya AD, et al. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: a meta-analysis. Am J Emerg Med. 2021;42:60–69.
   PubMed Web of Science ®Google Scholar
• Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021;40:110–114.
   PubMed Web of Science ®Google Scholar
• Yan W, Chen D, Bigambo FM, et al. Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis. BMC Infect Dis. 2021;21(1):156.
   PubMed Web of Science ®Google Scholar
• Ulloque-Badaracco JR, Salas-Tello WI, Al-Kassab-Cordova A, et al. Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 patients: a systematic review and meta-analysis. Int J Clin Pract. 2021;6:e14596.
   Google Scholar
• Li X, Liu C, Mao Z, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;24(1):647.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute; 2013 [cited 2021 July 9]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Borenstein M, Hedges LV, Higgins JP, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111.
   PubMed Web of Science ®Google Scholar
• Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;47:15–17.
   Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046–1055.
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–463.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Chen H, Chen R, Yang H, et al. Development and validation of a nomogram using on admission routine laboratory parameters to predict in-hospital survival of patients with COVID-19. J Med Virol. 2021;93(4):2332–2339.
   PubMed Web of Science ®Google Scholar
• Chen L, Yu J, He W, et al. Risk factors for death in 1859 subjects with COVID-19. Leukemia. 2020;34(8):2173–2183.
   PubMed Web of Science ®Google Scholar
• Correal JCD, Solorzano VEF, Damasco PH, et al. Risk factors associated with mortality in patients hospitalized for coronavirus disease 2019 in Rio de Janeiro, Brazil. Rev Soc Bras Med Trop. 2021;54:e0878–2020.
   PubMed Web of Science ®Google Scholar
• Diaz-Velez C, Urrunaga-Pastor D, Romero-Cerdan A, et al. Risk factors for mortality in hospitalized patients with COVID-19 from three hospitals in Peru: a retrospective cohort study. F1000Res. 2021;10:224.
   PubMedGoogle Scholar
• Dong YM, Sun J, Li YX, et al. Development and validation of a nomogram for assessing survival in patients with COVID-19 pneumonia. Clin Infect Dis. 2021;72(4):652–660.
   PubMed Web of Science ®Google Scholar
• Fois AG, Paliogiannis P, Scano V, et al. The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients. Molecules. 2020;25(23):5725.
   PubMed Web of Science ®Google Scholar
• Hassan AT, Elmoniem AEA, Abdelrady MM, et al. Challenges in steroid and anticoagulant therapy in severe COVID-19 pneumonia: a prospective study. Antibiotics. 2021;10(10). DOI:10.3390/antibiotics10101214.
   Google Scholar
• Ioannou GN, Locke E, Green P, et al. Risk factors for hospitalization, mechanical ventilation, or death among 10131 US veterans with SARS-CoV-2 infection. JAMA Network Open. 2020;3(9):e2022310.
   PubMed Web of Science ®Google Scholar
• Jiang J, Zhong W, Huang W, et al. Development and validation of a predictive nomogram with age and laboratory findings for severe COVID-19 in Hunan Province, China. Ther Clin Risk Manag. 2022;18:579–591.
   PubMed Web of Science ®Google Scholar
• Li C, Chen Q, Wang J, et al. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China. Aging (Albany NY). 2020;12(16):15938–15945.
   PubMedGoogle Scholar
• Lian J, Jin C, Hao S, et al. High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study. Aging (Albany NY). 2020;12(14):13849–13859.
   PubMedGoogle Scholar
• Liu F, Zhang Q, Huang C, et al. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics. 2020;10(12):5613–5622.
   PubMed Web of Science ®Google Scholar
• Liu YP, Li GM, He J, et al. Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study. Ann Transl Med. 2020;8(10):635.
   PubMed Web of Science ®Google Scholar
• Mutinelli-Szymanski P, Hude I, Merle E, et al. Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients. Clin Kidney J. 2021;14(1):124–131.
   PubMed Web of Science ®Google Scholar
• Oguz EG, Yeter HH, Akcay OF, et al. Predictive value of neutrophil-to-lymphocyte ratio in terms of need for intensive care unit and mortality in maintenance hemodialysis patients with COVID −19. Hemodial Int. 2022;26(3):377–385.
   PubMed Web of Science ®Google Scholar
• Ok F, Erdogan O, Durmus E, et al. Predictive values of blood urea nitrogen/creatinine ratio and other routine blood parameters on disease severity and survival of COVID-19 patients. J Med Virol. 2021;93(2):786–793.
   PubMed Web of Science ®Google Scholar
• Olivieri F, Sabbatinelli J, Bonfigli AR, et al. Routine laboratory parameters, including complete blood count, predict COVID-19 in-hospital mortality in geriatric patients. Mech Ageing Dev. 2022;204:111674.
   PubMed Web of Science ®Google Scholar
• Pitre T, Jones A, Su J, et al. Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: a retrospective cohort study. Intern Emerg Med. 2021;16(6):1573–1582.
   PubMed Web of Science ®Google Scholar
• Rashad A, Mousa S, Nafady-Hego H, et al. Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either dexamethasone or tocilizumab. Sci Rep. 2021;11(1):8816.
   PubMed Web of Science ®Google Scholar
• Seong GM, Baek AR, Baek MS, et al. Comparison of clinical characteristics and outcomes of younger and elderly patients with severe COVID-19 in Korea: a retrospective multicenter study. J Pers Med. 2021;11(12):1258.
   PubMed Web of Science ®Google Scholar
• Tatum D, Taghavi S, Houghton A, et al. Neutrophil-to-lymphocyte ratio and outcomes in louisiana COVID-19 patients. Shock. 2020;54(5):652–658.
   PubMed Web of Science ®Google Scholar
• Torres-Ruiz J, Perez-Fragoso A, Maravillas-Montero JL, et al. Redefining COVID-19 severity and prognosis: the role of clinical and immunobiotypes. Front Immunol. 2021;12:689966.
   PubMed Web of Science ®Google Scholar
• Vafadar Moradi E, Teimouri A, Rezaee R, et al. Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality. Am J Emerg Med. 2021;40:11–14.
   PubMed Web of Science ®Google Scholar
• Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhou Y, Wang X, et al. Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score-matching analysis. Respir Res. 2020;21(1):172.
   PubMed Web of Science ®Google Scholar
• Ye W, Chen G, Li X, et al. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19. Respir Res. 2020;21(1):169.
   PubMed Web of Science ®Google Scholar
• Yu Y, Ye J, Chen M, et al. Malnutrition prolongs the hospitalization of patients with COVID-19 infection: a clinical epidemiological analysis. J Nutr Health Aging. 2021;25(3):369–373.
   PubMedGoogle Scholar
• Zhang S, Guo M, Duan L, et al. Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study. Crit Care. 2020;24(1):438.
   PubMed Web of Science ®Google Scholar
• Nunez I, Priego-Ranero AA, Garcia-Gonzalez HB, et al. Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients. Clin Immunol. 2021;225:108682.
   PubMed Web of Science ®Google Scholar
• Al Mutair A, Al Mutairi A, Zaidi ARZ, et al. Clinical predictors of COVID-19 mortality among patients in intensive care units: a retrospective study. Int J Gen Med. 2021;14:3719–3728.
   PubMed Web of Science ®Google Scholar
• Alguwaihes AM, Al-Sofiani ME, Megdad M, et al. Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study. Cardiovasc Diabetol. 2020;19(1):205.
   PubMedGoogle Scholar
• Fu W, Chen C, Chen XL, et al. A U-shaped association between baseline neutrophil count and COVID-19-related mortality: a retrospective cohort study. J Med Virol. 2021;93(7):4265–4272.
   PubMed Web of Science ®Google Scholar
• Hakami A, Badedi M, Elsiddig M, et al. Clinical characteristics and early outcomes of hospitalized COVID-19 patients with end-stage kidney disease in Saudi Arabia. Int J Gen Med. 2021;14:4837–4845.
   PubMed Web of Science ®Google Scholar
• Holler JG, Eriksson R, Jensen TO, et al. First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study. BMC Infect Dis. 2021;21(1):39.
   PubMed Web of Science ®Google Scholar
• Huang Y, Hu Z, Hu D, et al. Clinical characteristics, risk factors, and cardiac manifestations of cancer patients with COVID-19. J Appl Physiol. 2021;131(3):966–976.
   PubMed Web of Science ®Google Scholar
• Wang JH, Chen RD, Yang HK, et al. Inflammation-associated factors for predicting in-hospital mortality in patients with COVID-19. J Med Virol. 2021;93(5):2908–2917.
   PubMed Web of Science ®Google Scholar
• Wu S, Du Z, Shen S, et al. Identification and validation of a novel clinical signature to predict the prognosis in confirmed coronavirus disease 2019 patients. Clin Infect Dis. 2020;71(12):3154–3162.
   PubMed Web of Science ®Google Scholar
• Xiong L, Zang X, Feng G, et al. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths. Aging (Albany NY). 2021;13(5):6289–6297.
   PubMedGoogle Scholar
• Zhang L, Fan T, Yang S, et al. Comparison of clinical characteristics of COVID-19 between elderly patients and young patients: a study based on a 28-day follow-up. Aging (Albany NY). 2020;12(20):19898–19910.
   PubMedGoogle Scholar
• Zhang X, Wang W, Wan C, et al. A predictive model for respiratory distress in patients with COVID-19: a retrospective study. Ann Transl Med. 2020;8(23):1585.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhang Y, Chi H, et al. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study. Clin Chem Lab Med. 2020;58(7):1106–1115.
   PubMed Web of Science ®Google Scholar
• Bell JS, James BD, Al-Chalabi S, et al. Community- versus hospital-acquired acute kidney injury in hospitalised COVID-19 patients. BMC Nephrol. 2021;22(1):269.
   PubMed Web of Science ®Google Scholar
• Bucci T, Galardo G, Gandini O, et al. Fibrosis-4 (FIB-4) index and mortality in COVID-19 patients admitted to the emergency department. Intern Emerg Med. 2022.
   PubMed Web of Science ®Google Scholar
• Cho SY, Park SS, Song MK, et al. Prognosis score system to predict survival for COVID-19 cases: a Korean Nationwide cohort study. J Med Internet Res. 2021;23(2):e26257.
   PubMed Web of Science ®Google Scholar
• Donoso-Navarro E, Arribas Gomez I, Bernabeu-Andreu FA. IL-6 and other biomarkers associated with poor prognosis in a cohort of hospitalized patients with COVID-19 in Madrid. Biomark Insights. 2021;16:11772719211013363.
   Web of Science ®Google Scholar
• Gao J, Zhong L, Wu M, et al. Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study. BMC Infect Dis. 2021;21(1):602.
   PubMed Web of Science ®Google Scholar
• Ji D, Zhang D, Xu J, et al. Prediction for progression risk in patients with COVID-19 pneumonia: the CALL score. Clin Infect Dis. 2020;71(6):1393–1399.
   PubMed Web of Science ®Google Scholar
• Jiang M, Li C, Zheng L, et al. A biomarker-based age, biomarkers, clinical history, sex (ABCS)-mortality risk score for patients with coronavirus disease 2019. Ann Transl Med. 2021;9(3):230.
   PubMed Web of Science ®Google Scholar
• Kamran SM, Mirza ZE, Moeed HA, et al. CALL score and RAS score as predictive models for coronavirus disease 2019. Cureus. 2020;12(11):e11368.
   PubMed Web of Science ®Google Scholar
• Katkat F, Karahan S, Varol S, et al. Mortality prediction with CHA2DS2-VASc, CHA2DS2-VASc-HS and R2CHA2DS2-VASc score in patients hospitalized due to COVID-19. Eur Rev Med Pharmacol Sci. 2021;25(21):6767–6774.
   PubMed Web of Science ®Google Scholar
• Kim DH, Park HC, Cho A, et al. Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection. Medicine (Baltimore). 2021;100(18):e25900.
   PubMed Web of Science ®Google Scholar
• Li M, Cheng B, Zeng W, et al. Analysis of the risk factors for mortality in adult COVID-19 patients in Wuhan: a multicenter study. Front Med (Lausanne). 2020;7:545.
   PubMedGoogle Scholar
• Lin A, He ZB, Zhang S, et al. Early risk factors for the duration of severe acute respiratory syndrome coronavirus 2 viral positivity in patients with coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2061–2065.
   PubMed Web of Science ®Google Scholar
• Liu M, Jiang H, Li Y, et al. Independent risk factors for the dynamic development of COVID-19: a retrospective study. Int J Gen Med. 2021;14:4349–4367.
   PubMed Web of Science ®Google Scholar
• Liu Z, Jin C, Wu CC, et al. Association between initial chest CT or clinical features and clinical course in patients with coronavirus disease 2019 pneumonia. Korean J Radiol. 2020;21(6):736–745.
   PubMed Web of Science ®Google Scholar
• Park JG, Kang MK, Lee YR, et al. Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study. BMJ Open. 2020;10(11):e041989.
   PubMed Web of Science ®Google Scholar
• Shen JX, Zhuang ZH, Zhang QX, et al. Risk factors and prognosis in patients with COVID-19 and liver injury: a retrospective analysis. J Multidiscip Healthc. 2021;14:629–637.
   PubMed Web of Science ®Google Scholar
• Stefan G, Mehedinti AM, Andreiana I, et al. Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania. Ren Fail. 2021;43(1):49–57.
   PubMed Web of Science ®Google Scholar
• Tomasoni D, Inciardi RM, Lombardi CM, et al. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID −19. Results of the cardio-COVID-Italy multicentre study. Eur J Heart Fail. 2020;22(12):2238–2247.
   PubMed Web of Science ®Google Scholar
• Trecarichi EM, Mazzitelli M, Serapide F, et al. Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility. Sci Rep. 2020;10(1):20834.
   PubMed Web of Science ®Google Scholar
• Viana-Llamas MC, Arroyo-Espliguero R, Silva-Obregon JA, et al. Hypoalbuminemia on admission in COVID-19 infection: an early predictor of mortality and adverse events. A retrospective observational study. Med Clin (Barc). 2021;156(9):428–436.
   PubMed Web of Science ®Google Scholar
• Wu R, Ai S, Cai J, et al. Predictive model and risk factors for case fatality of COVID-19: a cohort of 21,392 cases in Hubei, China. Innovation. 2020;1. 100022.
   Google Scholar
• Xian J, Pei X, Lu W, et al. The clinical value of bedside ultrasound in predicting the severity of coronavirus disease-19 (COVID-19). Ann Transl Med. 2021;9(4):336.
   PubMed Web of Science ®Google Scholar
• Yang B, Chang X, Huang J, et al. The role of IL-6/lymphocyte ratio in the peripheral blood of severe patients with COVID-19. Int Immunopharmacol. 2021;97:107569.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Ma Y, Zeng H, et al. Simple nomogram based on initial laboratory data for predicting the probability of ICU transfer of COVID-19 patients: multicenter retrospective study. J Med Virol. 2021;93(1):434–440.
   PubMed Web of Science ®Google Scholar
• Chen R, Sang L, Jiang M, et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020;146(1):89–100.
   PubMed Web of Science ®Google Scholar
• Fumagalli C, Rozzini R, Vannini M, et al. Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study. BMJ Open. 2020;10(9):e040729.
   PubMed Web of Science ®Google Scholar
• de Guadiana-Romualdo L G, Morell-Garcia D, Morales-Indiano C, et al. Characteristics and laboratory findings on admission to the emergency department among 2873 hospitalized patients with COVID-19: the impact of adjusted laboratory tests in multicenter studies. A multicenter study in Spain (BIOCOVID-Spain study). Scand J Clin Lab Invest. 2021;81(3):187–193.
   PubMed Web of Science ®Google Scholar
• Li K, Zhang C, Qin L, et al. A nomogram prediction of length of hospital stay in patients with COVID-19 pneumonia: a retrospective cohort study. Dis Markers. 2021;2021:5598824.
   PubMed Web of Science ®Google Scholar
• De Ardanaz L S, Andreu-Ubero JM, Navidad-Fuentes M, et al. Tocilizumab in COVID-19: factors associated with mortality before and after treatment. Front Pharmacol. 2021;12:620187.
   PubMed Web of Science ®Google Scholar
• Turgutalp K, Ozturk S, Arici M, et al. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19. BMC Nephrol. 2021;22(1):29.
   PubMed Web of Science ®Google Scholar
• Yu J, Nie L, Wu D, et al. Prognostic value of a clinical biochemistry-based nomogram for coronavirus disease 2019. Front Med (Lausanne). 2020;7:597791.
   PubMed Web of Science ®Google Scholar
• Azuero A. A note on the magnitude of hazard ratios. Cancer. 2016;122(8):1298–1299.
   PubMed Web of Science ®Google Scholar
• Zini G, Bellesi S, Ramundo F, et al. Morphological anomalies of circulating blood cells in COVID −19. Am J Hematol. 2020;95(7):870–872.
   PubMed Web of Science ®Google Scholar
• Reusch N, De Domenico E, Bonaguro L, et al. Neutrophils in COVID-19. Front Immunol. 2021;12:652470.
   PubMed Web of Science ®Google Scholar
• McElvaney OJ, McEvoy NL, McElvaney OF, et al. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med. 2020;202(6):812–821.
   PubMed Web of Science ®Google Scholar
• McKenna E, Wubben R, Isaza-Correa JM, et al. Neutrophils in COVID-19: not innocent bystanders. Front Immunol. 2022;13:864387.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Yalavarthi S, Shi H, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):e138999.
   Web of Science ®Google Scholar
• Wang J, Li Q, Yin Y, et al. Excessive neutrophils and neutrophil extracellular traps in COVID-19. Front Immunol. 2020;11:2063.
   PubMed Web of Science ®Google Scholar
• Zhang D, Guo R, Lei L, et al. Frontline science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J Leukoc Biol. 2021;109(1):13–22.
   PubMed Web of Science ®Google Scholar
• Fan BE, Chong VCL, Chan SSW, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):E131–E4.
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–637.
   PubMed Web of Science ®Google Scholar
• Iacono KT, Brown AL, Greene MI, et al. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol. 2007;83(3):283–295.
   PubMed Web of Science ®Google Scholar
• Wang K, Chen W, Zhang Z, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020;5(1):283.
   PubMed Web of Science ®Google Scholar
• Bellesi S, Metafuni E, Hohaus S, et al. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients. Br J Haematol. 2020;191(2):207–211.
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Netea MG, Rovina N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27(6):992–1000 e3.
   PubMed Web of Science ®Google Scholar
• Penaloza HF, Lee JS, Ray P. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease. PLoS Pathog. 2021;17(9):e1009850.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Pioggia G, Negrini S. Vitamin D and Covid-19: an update on evidence and potential therapeutic implications. Clin Mol Allergy. 2020;18(1):23.
   PubMedGoogle Scholar
• Maddur MS, Vani J, Lacroix-Desmazes S, et al. Autoimmunity as a predisposition for infectious diseases. PLoS Pathog. 2010;6(11):e1001077.
   PubMed Web of Science ®Google Scholar
• Murdaca G, Gerosa A, Paladin F, et al. Vitamin D and microbiota: is there a link with allergies? Int J Mol Sci. 2021;22(8):4288.
   PubMed Web of Science ®Google Scholar
• Yamamoto EA, Jorgensen TN. Relationships between vitamin D, gut microbiome, and systemic autoimmunity. Front Immunol. 2019;10:3141.
   PubMed Web of Science ®Google Scholar
• Ronchetti S, Ricci E, Migliorati G, et al. How glucocorticoids affect the neutrophil life. Int J Mol Sci. 2018;19(12):4090.
   PubMed Web of Science ®Google Scholar
• Olnes MJ, Kotliarov Y, Biancotto A, et al. Effects of systemically administered hydrocortisone on the human immunome. Sci Rep. 2016;6(1):23002.
   PubMedGoogle Scholar
• Martincic Z, Skopec B, Rener K, et al. Severe immune thrombocytopenia in a critically ill COVID-19 patient. Int J Infect Dis. 2020;99:269–271.
   PubMed Web of Science ®Google Scholar
• Group RC, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693–704.
   PubMed Web of Science ®Google Scholar